BackgroundCheck.run
Search For

David C Bom, 5512549 Elliot Ln, Huntley, IL 60142

Known as:
David Mariacristina Bom David B Bom David E Bom Dave C Bom Mariacristina Bom

David Bom Phones & Addresses

12549 Elliot Ln, Huntley, IL 60142    513-2451936   

9983 Weatherly Ct, Cincinnati, OH 45252    513-3854089   

8534 Althaus Rd, Cincinnati, OH 45247    513-3858659   

Brownsburg, IN   

1000 Vineyard Ave, Broadview Heights, OH 44147    440-8779939   

Cleveland, OH   

3543 Tates Creek Rd, Lexington, KY 40517   

Pittsburgh, PA   

Miamiville, OH   

Social networks

David C Bom

Linkedin

Work

Company: Sensient technologies corporation Apr 2012 to Sep 2012 Position: Innovation scientist

Education

Degree: Master of Business Administration, Masters School / High School: Xavier University 2014 to 2016 Specialities: Management

Languages

English • German • Italian

Industries

Food Production
Get Report
Control this profile

Mentions for David C Bom

David Bom resumes & CV records

Resumes

David Bom Photo 18

Technology Development Manager

Location:
9983 Weatherly Ct, Cincinnati, OH 45252
Industry:
Food Production
Work:
Sensient Technologies Corporation Apr 2012 - Sep 2012
Innovation Scientist Sensient Technologies Corporation Apr 2012 - Sep 2012
Technology Development Manager Givaudan Sep 2005 - Mar 2012
Research Scientist Athersys 2002 - 2005
Scientist
Education:
Xavier University 2014 - 2016
Master of Business Administration, Masters, Management University of Kentucky 2000 - 2002
University of Pittsburgh 1994 - 2000
Doctorates, Doctor of Philosophy, Organic Chemistry University of Cincinnati 1988 - 1993
Bachelors, Bachelor of Science, Chemistry
Languages:
English
German
Italian

Publications & IP owners

Us Patents

Tricyclic Heteroaryl Piperazines, Pyrrolidines And Azetidines As Serotonin Receptor Modulators

US Patent:
7423056, Sep 9, 2008
Filed:
Sep 1, 2005
Appl. No.:
11/217991
Inventors:
Youssef L. Bennani - Shaker Heights OH, US
David C. Bom - Broadview Heights OH, US
Michael J. Robarge - Burton OH, US
Assignee:
Athersys, Inc. - Cleveland OH
International Classification:
A61K 31/40
C07D 209/56
C07D 495/02
US Classification:
514411, 548416, 548427, 548429, 548430, 514410
Abstract:
The present invention generally relates to a series of compounds, to pharmaceutical compositions containing the compounds, and to use of the compounds and compositions as therapeutic agents. More specifically, compounds of the present invention are hexahydroazepinoindole and octahydroazepinoindole compounds. These compounds are serotonin receptor (5-HT) ligands and are useful for treating diseases, disorders, and conditions wherein modulation of the activity of serotonin receptors (5-HT) is desired (e. g. anxiety, depression and obesity).

Substituted Azepine Derivatives As Serotonin Receptor Modulators

US Patent:
7718647, May 18, 2010
Filed:
Jun 29, 2005
Appl. No.:
11/170266
Inventors:
Youssef L. Bennani - Shaker Heights OH, US
Michael J. Robarge - University Heights OH, US
David C. Bom - Broadview Heights OH, US
Norbert Varga - Cleveland Heights OH, US
Lawrence N. Tumey - Fairview Park OH, US
Assignee:
Athersys, Inc. - Cleveland OH
International Classification:
A61P 25/00
A61K 31/55
C07D 223/16
US Classification:
514215, 540593
Abstract:
The present invention generally relates to a series of compounds, to pharmaceutical compositions containing the compounds, and to use of the compounds and compositions as therapeutic agents. More specifically, compounds of the present invention are hexahydroazepinoindole and octahydroazepinoindole compounds. These compounds are serotonin receptor (5-HT) ligands and are useful for treating diseases, disorders, and conditions wherein modulation of the activity of serotonin receptors (5-HT) is desired (e. g. anxiety, depression and obesity).

Amide Addition Reaction

US Patent:
7880011, Feb 1, 2011
Filed:
Jul 15, 2008
Appl. No.:
12/173447
Inventors:
Stefan Michael Furrer - Cincinnati OH, US
David C. Bom - Cincinnati OH, US
David Max Dastrup - Liberty Township OH, US
Ioana Maria Ungureanu - Cincinnati OH, US
Assignee:
Givandan, S.A. - Vemier
International Classification:
C07D 213/40
US Classification:
546336, 546337
Abstract:
A method of making a compound of formula IIThe method is useful for the inexpensive manufacture of certain commercially-valuable compounds, including some that have desirable cooling properties.

Thiophenyl And Pyrrolyl Azepines As Serotonin 5-Htreceptor Ligands And Uses Thereof

US Patent:
7893051, Feb 22, 2011
Filed:
Jan 17, 2007
Appl. No.:
11/654979
Inventors:
L. Nathan Tumey - Pawcatuck CT, US
David C. Bom - Cincinnati OH, US
Youssef L. Bennani - Boston MA, US
Michael J. Robarge - Chagrin Falls OH, US
Assignee:
Athersys, Inc. - Cleveland OH
International Classification:
A61P 25/00
A61K 31/55
C07D 487/02
C07D 223/16
US Classification:
51421202, 514215, 540543, 540578, 540586, 540593
Abstract:
The present invention generally relates to a series of compounds, to pharmaceutical compositions containing the compounds, and to use of the compounds and compositions as therapeutic agents. More specifically, compounds of the present invention are thiophenyl and pyrrolyl azepine compounds. These compounds are serotonin receptor (5-HT) ligands and are useful for treating diseases, disorders, and conditions wherein modulation of the activity of serotonin receptors (5-HT) is desired (e. g. addiction, anxiety, depression, obesity, and others).

Cyclic N-Hydroxy Imides As Inhibitors Of Flap Endonuclease And Uses Thereof

US Patent:
7947691, May 24, 2011
Filed:
Jul 20, 2005
Appl. No.:
11/632920
Inventors:
Lawrence N. Tumey - New Windsor NY, US
Youssef Bennani - Shaker Heights OH, US
Bayard Huck - University Heights OH, US
David C. Bom - Broadview Heights OH, US
Assignee:
Athersys, Inc. - Cleveland OH
International Classification:
C07D 495/04
C07D 491/08
A61K 31/519
US Classification:
5142601, 544278
Abstract:
Acrylic n-hydroxy imides and their use in pharmaceutical compositions and in the inhibition of flap endonuclease are disclosed.

Tricyclic Heteroaryl Piperazines, Pyrrolidines And Azetidines As Serotonin Receptor Modulators

US Patent:
7981919, Jul 19, 2011
Filed:
Aug 5, 2008
Appl. No.:
12/221668
Inventors:
Youssef L. Bennani - Shaker Heights OH, US
David C. Bom - Cincinnati OH, US
Michael J. Robarge - Burton OH, US
Assignee:
Athersys, Inc. - Cleveland OH
International Classification:
A61K 31/40
C07D 209/56
US Classification:
514411, 548427, 548430, 514410
Abstract:
The present invention generally relates to a series of compounds, to pharmaceutical compositions containing the compounds, and to use of the compounds and compositions as therapeutic agents. More specifically, compounds of the present invention are hexahydroazepinoindole and octahydroazepinoindole compounds. These compounds are serotonin receptor (5-HT) ligands and are useful for treating diseases, disorders, and conditions wherein modulation of the activity of serotonin receptors (5-HT) is desired (e. g. anxiety, depression and obesity).

Cooling Compounds

US Patent:
8309598, Nov 13, 2012
Filed:
Dec 19, 2008
Appl. No.:
12/339184
Inventors:
David C. Bom - Cincinnati OH, US
Assignee:
Givaudan S.A. - Vernier
International Classification:
A61K 31/39
A61K 31/385
C07D 327/06
C07D 339/08
US Classification:
514434, 549 15
Abstract:
A method of providing a cooling sensation to the skin or the mucous membranes of the body, comprising the application thereto of at least one compound of the Formula I.

Substituted Azepine Derivatives As Serotonin Receptor Modulators

US Patent:
2010019, Jul 29, 2010
Filed:
Apr 1, 2010
Appl. No.:
12/752601
Inventors:
Youssef L. Bennani - Shaker Heights OH, US
Michael J. Robarge - Burton OH, US
David C. Bom - Cincinnati OH, US
Norbert Varga - Cleveland Heights OH, US
Lawrence N. Tumey - Fairview Park OH, US
International Classification:
A61K 31/55
C07D 495/04
C07D 495/10
C07D 495/06
A61P 3/04
A61P 25/22
A61P 25/24
A61P 25/30
US Classification:
51421202, 540593, 514215, 540543, 540586
Abstract:
The present invention generally relates to compounds and pharmaceutical compositions containing the compounds. More specifically, compounds of the present invention are hexahydroazepinoindole and octahydroazepinoindole compounds. These compounds are serotonin receptor (5-HT) ligands and are useful for treating diseases, disorders, and conditions wherein modulation of the activity of serotonin receptors (5-HT) is desired (e.g. anxiety, depression and obesity).

Possible Relatives

Jerry L Bom  Richard M Bom  Steven R Bom  David Last  David W Johnson  David Stamps  David L Stanard  David M Stanbery  David A Stanchfield  David J Stanciel 

NOTICE: You may not use BackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. BackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.